[Skip to Navigation]
Invited Commentary
September 2018

Opportunities for Early Detection of Endometrial Cancer in Women With Postmenopausal Bleeding

Author Affiliations
  • 1Department of Obstetrics and Gynecology, Women and Infants Hospital, Providence, Rhode Island
  • 2Warren Alpert Medical School of Brown University, Providence, Rhode Island
  • 3Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, San Francisco
JAMA Intern Med. 2018;178(9):1222-1223. doi:10.1001/jamainternmed.2018.2819

Endometrial cancer is the most common gynecologic malignancy and the fourth most common cancer among women in the United States.1 In 2018, there will be an estimated 63 230 women diagnosed with endometrial cancer.1 Currently, there is no effective endometrial cancer screening strategy for women who are asymptomatic. Fortunately, endometrial cancer is typically diagnosed in an early stage; 67% of women present with stage I or II disease confined to the uterus, at which point there is a 95% 5-year survival.2

Add or change institution